Progestagens and Corticosteroids in the Management Cancer Cachexia

作者: Davide Tassinari , Marco Maltoni

DOI: 10.1007/978-88-470-0552-5_64

关键词:

摘要: Over the past few years, many authors have approached problem of treatment cancer cachexia focusing on either knowledge main pathogenetic events, or outcomes in terms symptoms improvement quality life [1] [8]. The relevance clinical investigations anorexia-cachexia has epidemiological and roots, considering that it is very frequent advanced terminal disease (up to 40% patients with disease, more than 80% patients), its manifestations often represent a source great concern for both relatives [5]. approach been directed towards different targets, can be aetiological, symptomatic according attention paid tumour growth, behaviour syndrome. However, mandatory define biological rationale therapeutic options, every approach, using an evidence-based model.

参考文章(113)
Paolo Lissoni, Fernando Brivio, Antonio Ardizzoia, Gabriele Tancini, Sandro Barni, Subcutaneous therapy with low-dose interleukin-2 plus the neurohormone melatonin in metastatic gastric cancer patients with low performance status. Tumori. ,vol. 79, pp. 401- 404 ,(1993) , 10.1177/030089169307900606
E. Roca, S. Carraro, R. Chacon, L. Cedaro, E. Bruera, Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer treatment reports. ,vol. 69, pp. 751- 754 ,(1985)
John L. Shuster, Ann M. Berger, Jamie H. Von Roenn, Principles and Practice of Palliative Care and Supportive Oncology ,(2012)
Michael J. Tisdale, Helen J. Smith, Maria J. Lorite, Effect of a cancer cachectic factor on protein synthesis/degradation in murine C2C12 myoblasts: modulation by eicosapentaenoic acid. Cancer Research. ,vol. 59, pp. 5507- 5513 ,(1999)
Jun Nakashima, Masaru Murai, Akira Miyajima, Shiro Baba, Munehisa Ueno, Masaaki Tachibana, Association between tumor necrosis factor in serum and cachexia in patients with prostate cancer Clinical Cancer Research. ,vol. 4, pp. 1743- 1748 ,(1998)
Eduardo Bruera, Catherine M. Neumann, Management of specific symptom complexes in patients receiving palliative care Canadian Medical Association Journal. ,vol. 158, pp. 1717- 1726 ,(1998)
K M Rowland, C L Loprinzi, E G Shaw, A W Maksymiuk, S A Kuross, S H Jung, J W Kugler, L K Tschetter, C Ghosh, P L Schaefer, D Owen, J H Washburn, T A Webb, J A Mailliard, J R Jett, Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study. Journal of Clinical Oncology. ,vol. 14, pp. 135- 141 ,(1996) , 10.1200/JCO.1996.14.1.135
E. Bruera, C.M. Neumann, E. Pituskin, K. Calder, G. Ball, J. Hanson, Thalidomide in patients with cachexia due to terminal cancer: Preliminary report Annals of Oncology. ,vol. 10, pp. 857- 859 ,(1999) , 10.1023/A:1008329821941
J P Simons, N K Aaronson, J F Vansteenkiste, G P ten Velde, M J Muller, B M Drenth, F L Erdkamp, E G Cobben, E J Schoon, J B Smeets, H C Schouten, M Demedts, H F Hillen, G H Blijham, E F Wouters, Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study. Journal of Clinical Oncology. ,vol. 14, pp. 1077- 1084 ,(1996) , 10.1200/JCO.1996.14.4.1077
Jon T. Albrecht, Todd W. Canada, Cachexia and anorexia in malignancy Hematology-oncology Clinics of North America. ,vol. 10, pp. 791- 800 ,(1996) , 10.1016/S0889-8588(05)70368-3